EX-99.1 2 ex_563425.htm EXHIBIT 99.1 ex_563425.htm

Exhibit 99.1

 

Natural Health Trends Reports Third Quarter 2023 Financial Results

 

  Total orders taken were roughly flat despite continued headwinds of a stronger dollar and trepid consumer sentiment
  Cash flows from operations improved $1.4 million
  Declared a quarterly cash dividend of $0.20 per share

 

HONG KONG – November 1, 2023 – Natural Health Trends Corp. (NASDAQ: NHTC), a leading direct-selling and e-commerce company that markets premium quality personal care, wellness and “quality of life” products under the NHT Global brand, today announced its financial results for the quarter ended September 30, 2023.

 

Third Quarter 2023 Financial Highlights

 

 

Revenue of $10.6 million decreased 9% compared to $11.7 million in the third quarter of 2022. The decrease in revenue was primarily due to the changes in deferred revenue in the two respective quarters. Deferred revenue decreased $603,000 and $1.4 million during the third quarter of 2023 and 2022, respectively, resulting in an $835,000 unfavorable revenue variance.

 

 

Operating loss was $292,000 compared to $145,000 in the third quarter of 2022.

 

 

Net income was $172,000, or $0.02 per diluted share, compared to $47,000, or breakeven per diluted share, in the third quarter of 2022.

 

 

The number of Active Members1 was down 6% to 34,660 at September 30, 2023 compared to 36,730 at June 30, 2023, and decreased 16% compared to 41,170 at September 30, 2022.

 

 

1

Natural Health Trends defines Active Members as those that have placed at least one product order with the Company during the preceding twelve-month period.

 

Year-to-Date 2023 Financial Highlights

 

 

Revenue of $33.0 million decreased 10% compared to $36.6 million in the first nine months of 2022. The revenue decrease was primarily due to the changes in deferred revenue in the two respective nine-month periods. Deferred revenue increased $651,000 during the first nine months of 2023, but decreased $3.3 million during the same period last year, resulting in a $3.9 million unfavorable revenue variance.

 

 

Operating loss was $1.4 million compared to $313,000 in the first nine months of 2022.

 

 

Net income was $210,000, or $0.02 per diluted share, compared to $125,000, or $0.01 per diluted share, in the first nine months of 2022.

 

Management Commentary

 

“Adapting to the current environment in which Chinese consumers are reluctant to spend or invest, we managed to generate orders on pace with those of last year. Orders grew 3% at a constant exchange rate compared to the third quarter of 2022, while year-to-date 2023 orders increased 8% compared to prior year. The reported decrease in revenue was largely due to changes in deferred revenue, partly because orders tended to be received later in the quarter this year. Importantly, our members remained responsive to our programs, demonstrating that our promotions, incentives and high-quality product offerings continue to resonate,” commented Chris Sharng, President of Natural Health Trends Corp.

 

Mr. Sharng continued, “Noteworthy to highlight are the signs of momentum extending to several of our other markets including Taiwan, Peru, North America and Japan, each of which delivered strong performance during the quarter. We’re hopeful that these signs of growth will continue supported by careful planning and execution to our strategies around digital enhancements, new product launches, geographic diversification and superior member support.”

 

1

 

Balance Sheet and Cash Flow

 

 

Net cash used in operating activities was $4.2 million in the first nine months of 2023 compared to $5.8 million in the first nine months of 2022. Before tax installment payments, the liability of which arises from the 2017 U.S. Tax Cuts and Jobs Act (the “Act Act”), cash used in operating activities was $1.2 million in the first nine months 2023, versus $4.2 million in the comparable period a year ago. Of the total Tax Act liability of $20.2 million, $11.2 million has been paid to date.

 

Total cash and cash equivalents were $58.4 million at September 30, 2023, down from $61.6 million at June 30, 2023.

 

On October 30, 2023, the Company’s Board of Directors declared a quarterly cash dividend of $0.20 on each share of common stock outstanding. The dividend will be payable on November 24, 2023 to stockholders of record as of November 14, 2023.

 

Third Quarter 2023 Financial Results Conference Call

 

Management will host a conference call to discuss the third quarter 2023 financial results today, Wednesday, November 1, 2023 at 11:30 a.m. Eastern Time. The conference call details are as follows:

 

Date:

Wednesday, November 1, 2023

Time:

11:30 a.m. Eastern Time / 8:30 a.m. Pacific Time

Dial-in:

1-877-407-0789 (Domestic)

1-201-689-8562 (International)

Conference ID:

13740859

Webcast:

https://viavid.webcasts.com/starthere.jsp?ei=1631150&tp_key=ea6cd96ef7

 

For those unable to participate during the live broadcast, a replay of the call will also be available from 2:30 p.m. Eastern Time on November 1, 2023 through 11:59 p.m. Eastern Time on November 8, 2023 by dialing 1-844-512-2921 (domestic) and 1-412-317-6671 (international) and referencing the replay pin number: 13740859.

 

About Natural Health Trends Corp.

 

Natural Health Trends Corp. (NASDAQ: NHTC) is an international direct-selling and e-commerce company operating through its subsidiaries throughout Asia, the Americas, and Europe. The Company markets premium quality personal care products under the NHT Global brand. Additional information can be found on the Company’s website at www.naturalhealthtrendscorp.com.

 

Forward-Looking Statements

 

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 -- Forward-looking statements in this press release do not constitute guarantees of future performance. Such forward-looking statements are subject to risks and uncertainties that could cause the Company’s actual results to differ materially from those anticipated. Such risks and uncertainties include the risks and uncertainties detailed under the caption “Risk Factors” in Natural Health Trends Corp.’s Annual Report on Form 10-K filed on March 3, 2023 with the Securities and Exchange Commission (SEC), as well as in subsequent reports filed this year with the SEC. The Company assumes no obligation to update any forward-looking information contained in this press release or with respect to the announcements described herein.

 

2

 

CONTACT:

 

Scott Davidson

Senior Vice President and Chief Financial Officer

Natural Health Trends Corp.

Tel (Hong Kong): +852-3107-0800

Tel (U.S.): 310-541-0888

investor.relations@nhtglobal.com

 

3

 

NATURAL HEALTH TRENDS CORP.

CONSOLIDATED BALANCE SHEETS

(In thousands, except share data) 

 

   

September 30, 2023

   

December 31, 2022

 
   

(Unaudited)

         

ASSETS

               

Current assets:

               

Cash and cash equivalents

  $ 58,412     $ 69,667  

Inventories

    4,882       4,525  

Other current assets

    3,675       3,359  

Total current assets

    66,969       77,551  

Property and equipment, net

    284       394  

Operating lease right-of-use assets

    3,549       3,992  

Restricted cash

    37       79  

Deferred tax asset

    303       195  

Other assets

    679       606  

Total assets

  $ 71,821     $ 82,817  

LIABILITIES AND STOCKHOLDERS’ EQUITY

               

Current liabilities:

               

Accounts payable

  $ 666     $ 810  

Income taxes payable

    4,092       2,972  

Accrued commissions

    2,589       2,943  

Other accrued expenses

    1,100       1,181  

Deferred revenue

    6,248       5,597  

Amounts held in eWallets

    4,154       4,895  

Operating lease liabilities

    1,182       1,135  

Other current liabilities

    747       905  

Total current liabilities

    20,778       20,438  

Income taxes payable

    5,054       9,098  

Deferred tax liability

    140       141  

Operating lease liabilities

    2,539       2,989  

Total liabilities

    28,511       32,666  

Stockholders’ equity:

               

Preferred stock

           

Common stock

    13       13  

Additional paid-in capital

    84,657       86,102  

Accumulated deficit

    (15,757 )     (9,056 )

Accumulated other comprehensive loss

    (1,267 )     (1,004 )

Treasury stock, at cost

    (24,336 )     (25,904 )

Total stockholders’ equity

    43,310       50,151  

Total liabilities and stockholders’ equity

  $ 71,821     $ 82,817  

 

4

 

NATURAL HEALTH TRENDS CORP. 

CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

(In thousands, except per share data)

 

   

Three Months Ended September 30,

   

Nine Months Ended September 30,

 
   

2023

   

2022

   

2023

   

2022

 

Net sales

  $ 10,615     $ 11,716     $ 32,987     $ 36,622  

Cost of sales

    2,689       3,098       8,386       9,398  

Gross profit

    7,926       8,618       24,601       27,224  

Operating expenses:

                               

Commissions expense

    4,361       4,863       13,861       15,370  

Selling, general and administrative expenses

    3,857       3,900       12,169       12,167  

Total operating expenses

    8,218       8,763       26,030       27,537  

Loss from operations

    (292 )     (145 )     (1,429 )     (313 )

Other income, net

    585       187       1,708       472  

Income before income taxes

    293       42       279       159  

Income tax provision (benefit)

    121       (5 )     69       34  

Net income

  $ 172     $ 47     $ 210     $ 125  

Net income per common share:

                               

Basic

  $ 0.02     $ 0.00     $ 0.02     $ 0.01  

Diluted

  $ 0.02     $ 0.00     $ 0.02     $ 0.01  

Weighted average common shares outstanding:

                               

Basic

    11,440       11,423       11,432       11,341  

Diluted

    11,454       11,423       11,449       11,423  

 

5

 

NATURAL HEALTH TRENDS CORP.

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

(In thousands)

 

   

Nine Months Ended September 30,

 
   

2023

   

2022

 

CASH FLOWS FROM OPERATING ACTIVITIES:

               

Net income

  $ 210     $ 125  

Adjustments to reconcile net income to net cash used in operating activities:

               

Depreciation and amortization

    130       156  

Share-based compensation

    123        

Noncash lease expense

    830       889  

Deferred income taxes

    (117 )     (2 )

Changes in assets and liabilities:

               

Inventories

    (420 )     140  

Other current assets

    (425 )     1,000  

Other assets

    (92 )     (44 )

Accounts payable

    (141 )     228  

Income taxes payable

    (2,923 )     (1,382 )

Accrued commissions

    (315 )     (1,055 )

Other accrued expenses

    (58 )     (540 )

Deferred revenue

    674       (3,209 )

Amounts held in eWallets

    (725 )     (1,150 )

Operating lease liabilities

    (812 )     (950 )

Other current liabilities

    (148 )     4  

Net cash used in operating activities

    (4,209 )     (5,790 )

CASH FLOWS FROM INVESTING ACTIVITIES:

               

Purchases of property and equipment

    (32 )     (130 )

Net cash used in investing activities

    (32 )     (130 )

CASH FLOWS FROM FINANCING ACTIVITIES:

               

Dividends paid

    (6,911 )     (6,855 )

Net cash used in financing activities

    (6,911 )     (6,855 )

Effect of exchange rates on cash, cash equivalents and restricted cash

    (145 )     (858 )

Net decrease in cash, cash equivalents and restricted cash

    (11,297 )     (13,633 )

CASH, CASH EQUIVALENTS AND RESTRICTED CASH, beginning of period

    69,746       84,365  

CASH, CASH EQUIVALENTS AND RESTRICTED CASH, end of period

  $ 58,449     $ 70,732  

SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES:

               

Right-of-use assets obtained in exchange for operating lease liabilities

  $ 115     $ 2,218  

 

6